New Johnson & Johnson data show high booster shot effectiveness

Data from a phase III trial demonstrate a 94-percent protection against Covid-19 with a Johnson & Johnson booster shot.
Photo: Jens Dresling
Photo: Jens Dresling
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN

An additional dose of Johnson & Johnson's Covid-19 vaccine has shown an effectiveness of 94 percent, the company just announced in the published results of a phase III trial.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading